These results also suggested that UBQLN2 pathology may favorize neuroinflammation and the reduction of UBQLN2 cytoplasmic accumulation may be a potential treatment approach to reduce glial cells activation observed in ALS. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.